Discovery of Homobivalent Bitopic Ligands of the Cannabinoid CB2 Receptor*.
Chemistry
; 26(68): 15839-15842, 2020 Dec 04.
Article
en En
| MEDLINE
| ID: mdl-32794211
Single chemical entities with potential to simultaneously interact with two binding sites are emerging strategies in medicinal chemistry. We have designed, synthesized and functionally characterized the first bitopic ligands for the CB2 receptor. These compounds selectively target CB2 versus CB1 receptors. Their binding mode was studied by molecular dynamic simulations and site-directed mutagenesis.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Receptor Cannabinoide CB2
Idioma:
En
Revista:
Chemistry
Asunto de la revista:
QUIMICA
Año:
2020
Tipo del documento:
Article
País de afiliación:
España